Author: admin

QUEBEC CITY , July 28, 2015 /CNW Telbec/ – CO2 Solutions Inc. (“CO2 Solutions” or the “Corporation”) (CST.V), the leader in the field of enzyme-enabled carbon capture technology, today announced the completion of the exploratory phase of its Chinese market initiative which had been undertaken with the assistance of Ercel Baker Inc.

Ercel Baker , principal of Ercel Baker Inc., was formerly an Executive Director of Staffing Programs at the Public Services Commission of Canada and during his tenure worked for many years with relevant Ministries and Commissions of the People’s Republic of China , advising and assisting in the reform of the Chinese civil service. Ercel Baker Inc. is a company that advises and assists North American organizations in exploring potential entry into the Chinese markets.

“The Chinese market for carbon capture has enormous potential, as was confirmed by Mr. Baker’s work done on behalf of our Corporation, as well as in a series of face to face meetings we had with Chinese government officials, industrialists and other potential stakeholders,” stated Evan Price , President and CEO of CO2 Solutions. “Our exploration of this market has built awareness of our company in China and positioned us for the future. We believe we can potentially exploit, in the mid-term, some of the opportunities presented to us through the work undertaken by Ercel Baker Inc.”

Carbon dioxide (CO2) enhanced oil recovery (EOR) has been successfully used in the US for around 40 years. The injection of CO2 into ageing oil fields to sweep residual oil has helped extend the production life of some fields by more than 25 years. The key enabler of this success has been the availability of a large volume of low-cost naturally occurring CO2, which has been tapped in the US to provide a regular supply to EOR projects.

However, the US remains the only nation to have discovered naturally occurring CO2 sources, apart from natural gas collections with a high CO2 content. As maturing oil production markets provide more opportunity for CO2 use in EOR, demand for CO2 has risen while supply volumes have not seen significant additions over the market’s 35+ year history.

There has therefore been a growing interest in capturing some of the approximately 32 billion tonnes of CO2 released into the atmosphere globally from anthropogenic sources such as power plants, and using this to boost production of oil from waning production areas. This creates opportunities in many more countries outside the US where CO2 EOR markets have the potential to grow. The intensifying link with carbon capture technology will mean that areas advanced in this technology with significant maturing oil areas will prosper in the CO2 EOR market.

This is the message of a report published today by Scottish Carbon Capture & Storage (SCCS) outlining a concept proposal to re-energise the deployment of CCS in the UK and Europe. The hub would serve as a central collection point for CO2 emissions from different sources across Europe, from where the greenhouse gas would be transported for permanent storage in rocks deep beneath the North Sea.

By starting with a modest industrial and power CCS cluster in Central Scotland that can make use of existing pipelines and offshore infrastructure to establish CO2 storage in the Central North Sea quickly and affordably, the study indicates how this could develop into a new large-scale industry for the UK while helping solve Europe’s CO2 storage challenge.

Agreement with CLEA Technologies B.V. provides CO2 Solution with advanced technology for industrial application of enzyme for carbon capture

QUEBEC CITY, June 1 /PRNewswire-FirstCall/ – CO2 Solution Inc. (“CO2 Solution” or the “Company”) is pleased to announce it has executed a Custom Immobilization Agreement (the “Agreement”) with CLEA Technologies B.V. (“CLEATECH”) (www.cleatechnologies.com) for the development of CLEATECH’s proprietary Cross Linked Enzyme Aggregate (“CLEA”) technology for the carbonic anhydrase enzyme used by CO2 Solution for carbon capture applications. As part of the Agreement, CO2 Solution obtains exclusive global rights to CLEATECH’s CLEA technology for the enzyme carbonic anhydrase until 2016, extendable thereafter upon commercial deployment. The CLEA technology is patent pending in the U.S. and Europe. Additionally, any new intellectual property developed under the Agreement by CLEATECH will be the sole property of CO2 Solution.

It is expected that the CLEA technology will provide for a robust method of using the carbonic anhydrase in CO2 Solution’s carbon capture process, and builds upon the proven commercial application of the CLEA technology for the fine chemicals and pharmaceutical industry. The CLEA technology provides an alternative to using soluble enzyme and may further improve overall economics of the process. Furthermore, the CLEA manufacturing process is proven, and relatively simple, allowing for expected ease of scale-up.